New biomarker test helps detect autoimmune-induced neuropsychiatric disorders

news-medical.net September 20, 2016

biomarker tests

A research team from the University of Oklahoma Health Sciences Center, led by Madeleine Cunningham, Ph.D., in conjunction with the National Institute of Mental Health, has developed the first-of-its-kind biomarker test to help detect autoimmune-induced neuropsychiatric disorders.

autism children inflammation research

Clinical Outcomes in Critically Ill COVID-19 Unvaccinated Patients Admitted to the ICU

Clinical Outcomes in Critically Ill COVID-19 Unvaccinated Patients Admitted to the ICU

10 Reasons for Pharmacy Professionals Presence in the ICU

10 Reasons for Pharmacy Professionals Presence in the ICU

Heat Shock Protein 27 in COVID-19 and non-COVID ARDS Pathogenesis

Heat Shock Protein 27 in COVID-19 and non-COVID ARDS Pathogenesis

Oxygenation Improvement in Hyperinflammatory Ovine ARDS Treated with Methylprednisolone

Oxygenation Improvement in Hyperinflammatory Ovine ARDS Treated with Methylprednisolone

Point of Care Ultrasound Made Easy

Coronavirus Disease 2019 (COVID-19): Epidemiology, Pathogenesis, Diagnosis, and Therapeutics

Pediatric Liver Intensive Care

Imaging the ICU Patient

Every Deep-Drawn Breath: A Critical Care Doctor on Healing, Recovery, and Transforming Medicine in the ICU

Case Files Emergency Medicine, Fourth Edition

Textbook of Neonatal Resuscitation

Sepsis Management: PIRO and MODS

COVID-19 Airway Management and Ventilation Strategy for Critically Ill Older Patients

Extracorporeal Life Support for Adults

Critical Care: A New Nurse Faces Death, Life, and Everything in Between